From the view of global, according to the data, the global POCT market in 2013 reached 16 billion U.S. dollars and will reach 24 billion U.S. dollars in 2018, a compound annual growth rate of 8% in 2013-2018, which will significantly exceed the growth of the entire IVD industry.
The POCT market in the United States in 2013 was 7.5 billion U.S. dollars, accounting for 47% of the total. The EU market was 4.87 billion U.S. dollars, accounting for 30% of the total. Japan's market is accounted for about 12% of the market, while POCT markets in developing countries such as China, India and Brazil is in lower base, but it owned the faster growth.
In 2016, the world's per capita expenditure was about US $ 8.5, that in developed countries reached US $ 25 and that in China was only about US $ 4.6. At the same time, China's POCT accounted for only 13.98% of IVD, significantly lower than the global POCT accounting for 27.38% of IVD and lower In Europe and the United States developed countries. With the advancement of grading diagnosis, POCT in our country usher in unprecedented opportunities for development, which is growing rapidly at a rate of over 20% each year. The future development of POCT is promising.